| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000039561 |
| Receipt No. | R000045115 |
| Scientific Title | Evaluation of long-term use safety of cream containing retinol palmitate : Open-Label Trial |
| Date of disclosure of the study information | 2020/03/04 |
| Last modified on | 2022/02/21 (Ver. 4) |
| Basic information | ||
| Public title | Evaluation of long-term use safety of cream containing retinol palmitate | |
| Acronym | Evaluation of using safety of MR cream | |
| Scientific Title | Evaluation of long-term use safety of cream containing retinol palmitate : Open-Label Trial | |
| Scientific Title:Acronym | Evaluation of long-term use safety of cream containing retinol palmitate | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult female | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluate safety of long-term continuous of using cosmetic cream |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Visual evaluation |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Use test sample for 52 weeks | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Subjects whose wrinkle class in the outer corner is 3 to 5 | |||
| Key exclusion criteria | 1. Subjects with cosmetic allergies
2. Subjects who are pregnant or lactating 3. Subjects with inflamed or scraped skin on face 4. Subjects who are judged as unsuitable for the study by the investigator for the other reason |
|||
| Target sample size | 70 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Japan Clinical Trial Association | ||||||
| Division name | N.A. | ||||||
| Zip code | 1600022 | ||||||
| Address | 5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo | ||||||
| TEL | 0364574666 | ||||||
| info@yakujihou.org | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Japan Clinical Trial Association | ||||||
| Division name | N.A. | ||||||
| Zip code | 1600022 | ||||||
| Address | 5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo | ||||||
| TEL | 0364574666 | ||||||
| Homepage URL | |||||||
| info@yakujihou.org | |||||||
| Sponsor | |
| Institute | Japan Clinical Trial Association |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Mebius Pharmaceutical Co.,Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board of Pharmaceutical Law Wisdoms |
| Address | 5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo |
| Tel | 0364574911 |
| master@yakujihou.net | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 95 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000045115 |